The World Bank and the African Union will work together to accelerate COVID-19 vaccinations for up to 400 million people across Africa, Reuters news agency reported on Tuesday.
In a joint statement made on on 21 June 2021, The World Bank and the African Union said the agreement will provide needed resources to the Africa Vaccine Acquisition Task Team (AVATT) initiative, allowing countries to purchase and deploy more vaccines.
This initiative will also complement efforts already underway by the COVAX vaccine-sharing programme, which is co-run by the WHO.
Reportedly, this new World Bank initiative comes amid shortages caused in part by manufacturing delays and supply disruptions from India, with cases and deaths rising as a third wave of COVID-19 infections sweeps across Africa.
No details were immediately available on the cost of the initiative, but the funds will reportedly come from the USD12bn the World Bank has made available for vaccine financing and distribution.
According to the World Bank, its expects to be supporting vaccination efforts in 50 countries, two thirds of which are in Africa, by the end of June 2021.
Pfizer reports positive Phase 3 data for ABRYSVO in adults at risk for RSV disease
Clover Bio announces SCB-1019 vaccine candidate Phase I trial data in initial young adult cohort
Sanofi launches Verorab for rabies prophylaxis in UK
BioVaxys expands patent portfolio for DPX delivery platform and advances DPX SurMAGE
YS Biopharma repays USD40m loan facility
Kintara Therapeutics and TuHURA Biosciences to merge
VGXI names new chief accounting officer
Moderna reports positive interim results from next-generation COVID-19 vaccine trial
Valneva launches Phase 1 trial for next-generation Zika vaccine
Circio Holding ASA confirms licensing deal with IOVaxis Therapeutics in China and Singapore
Everest Medicines names new chief medical officer and chief product officer
Pfizer's PREVENAR 20 gains European Commission approval for paediatric pneumococcal vaccine